Routt, E. (2019) “Long Term Outcomes for Basal Cell Carcinoma Treated with Vismodegib Extended Alternate Day Dosing”, SKIN The Journal of Cutaneous Medicine, 3(2), pp. 150–151. doi: 10.25251/skin.3.2.32.